Carlisle Cos. News, Carlisle Cos. Quote, CSL Quote

Carlisle Cos. (NY:CSL) Delayed: 367.41 -1.43 (0.39%)

Prev. Close

$368.84

Open

$371.57

52 Wk High

$114.49

52 Wk Low

$75.17

Day High

$373.45

Day Low

$365.79

P/E

101.78

EPS

$3.61

Volume

264,577

Friends, Peers and Foes (?): CSLLY, ARCT, QURE, APH, TVTX (more...)

Apr 18, 2024 07:26 AM Carlisle (CSL) PT Raised to $412 at Oppenheimer
Apr 11, 2024 04:05 PM Carlisle Companies to Announce First Quarter 2024 Results on April 25, 2024
Apr 4, 2024 08:00 AM Armstrong World Industries Names Dawn Kirchner-King as SVP, Chief Human Resources Officer
Apr 3, 2024 05:31 PM Form 8-K CARLISLE COMPANIES INC For: Apr 03
Apr 3, 2024 02:26 AM Goldman Sachs Starts Carlisle (CSL) at Buy, 'Emerging Re-Roof Cycle Furthered by Company-Specific Initiatives'
Apr 1, 2024 07:22 AM Carlisle (CSL) PT Raised to $440 at Loop Capital
Mar 28, 2024 03:00 AM Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
Mar 20, 2024 07:36 AM Carlisle (CSL) PT Raised to $405 at Oppenheimer
Mar 20, 2024 06:02 AM Form 8-K CARLISLE COMPANIES INC For: Mar 18
Mar 19, 2024 07:00 AM Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure

Entities mentioned with CSL